SGLT2 inhibition does not reduce hepatic steatosis in overweight, insulin resistant patients without type 2 diabetes

Marjot T., Green C., Mcneil C., Cornfield T., Hazlehurst J., Moolla A., White S., Francis J., Neubauer S., Cobbold J., Hodson L., Tomlinson J.

DOI

10.1016/S0618-8278(19)30119-7

Type

Conference paper

Publication Date

04/2019

Volume

70

Pages

E68 - E68

Permalink Original publication